Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Advent to sell generic unit to PE firm GTCR for US$ 4.8 billion; Novo shapes up for obesity race by cutting 9,000 jobs

In this week’s news, Advent International has agreed to sell the Czech generic drugmaker Zentiva to private equity firm G...

Impressions : 536

Novartis inks US$ 5.2 bn cardiology deal with China's Argo, US$ 2 bn deal with Arrowhead; FDA okays first GLP-1 generic for weight

Novartis signed two deals this week — a US$ 5.2 billion cardiology deal with China’s Argo Biopharmaceuticals, and a...

Impressions : 681

White House sacks CDC director; FDA okays Ionis' Dawnzera, first RNA-based preventive for hereditary angioedema

The Trump administration has fired US Centers for Disease Control and Prevention (CDC) Director Susan Monarez, post a policy di...

Impressions : 989

FDA grants accelerated approval to Wegovy for treating MASH; Lilly, Superluminal ink US$1.3 bn AI deal to treat obesity

This week’s Phispers brings you updates on key drug approvals. The US Food and Drug Administration (FDA) has granted acce...

Impressions : 1306

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Advent to sell generic unit to PE firm GTCR for US$ 4.8 billion; Novo shapes up for obesity race by cutting 9,000 jobs

Novartis inks US$ 5.2 bn cardiology deal with China's Argo, US$ 2 bn deal with Arrowhead; FDA okays first GLP-1 generic for weight

White House sacks CDC director; FDA okays Ionis' Dawnzera, first RNA-based preventive for hereditary angioedema

FDA grants accelerated approval to Wegovy for treating MASH; Lilly, Superluminal ink US$1.3 bn AI deal to treat obesity

Celltrion's Biologics Stoboclo Receives Suppl Approval in US

Celltrion's Biologics Osenvelt Receives Suppl Approval in US

Horizon's Biologics Tepezza Receives Suppl Approval in US

Aurobindo's Generics Deferasirox Receives Approval in US

Epic's Generics Ivermectin Receives Approval in US

Aurobindo's Generics Prochlorperazine Receives Approval in US

Alembic's Generics Phytonadione Receives Approval in US

MSN's Generics Dapagliflozin Receive Tentative Approval in US

Genentech's Biologics Susvimo Receives Supple Approval in US

Torrent's Generics Pazopanib HCl Receives Approval in US

Mera Cannabis Corp.'s Fails EDQM inspection

Ilko Ilac Sanayi Ve Ticaret A.S's Fails EDQM inspection

Enforcement Report - Week of September 10, 2025

Hikal Limited Recieves Warning Letter

FDA Issues Form 483 to GenoGenix

Enforcement Report - Week of September 3, 2025

Wisconsin Pharmacal Recieves Warning Letter

Amneal Pharmaceuticals Recieves Warning Letter

FDA Issues Form 483 to AnazaoHealth Corporation

Green Lumber Alerts Consumers on Counterfeits After FDA Findings

Novartis Signs up to $5.7 B licensing deal with Monte Rosa

Phrontline Biopharma Initiates Phase 1 Trial for TJ101

India Life Sciences Sector Moves to AI-Driven Regulatory Files

Lion TCR Gets Triple FDA Milestones for Hepatitis B IND Clearance

Innate Pharma Participation at 25th European Midcap Event

Curatis Achieves Development Milestone for C-PTBE-01 Amid Growth

Under Trump, FDA Seeks to Abandon Expert Reviews of New Drugs

Gilead Beats Whistleblower Lawsuit over Hepatitis C drugs

AstraZeneca pauses $270 Million Investment in Britain

Wellness Innercell Tops Health Nutrition & Cosmetics Sector

Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution

AbbVie Shares Hit Record on Immunology Drug Exclusivity Till 2037

CDSCO Removes Voglibose+Metformin Hcl 500mg from April List

NastLaw Announces Settlement in Generic Pharma Pricing Litigation

CVS Sues Takeda Over 'Pay-For-Delay' Scheme

Lupin Gets FDA Nod for Risperidone Long-Acting Injectable

Alembic Receives FDA Final Approval for Phytonadione Injectable

Private equity GTCR strikes $4.8 billion deal to buy Zentiva

A.forall Boosts US Generics Portfolio

Trump Excludes Generics from US-Japan Trade Deal

Phrontline Biopharma Initiates Phase 1 Trial for TJ101

Ryoncil Launch Success Highlighted at Global Health Conferences

OranoMed Hits Milestone in Facility Build for Lead-212 Therapies

Merck touts Capvaxive's potential to provide protection for kids

Sanofi's SAR402663 Granted Fast Track Status for Neovascular AMD

Inside the Commercial Growing Pains of Hemophilia Gene Therapies

Kanazawa University research: Thermal trigger

CVMP Backs Zoetis' Portela for Cat Osteoarthritis Pain Relief

Vor Bio Joins Stifel 2025 Virtual Immunology, Inflammation Forum

ProPhase Holders 75%+ Approve All Proposals at Sept 9 Meeting

Alembic Pharma Gets EIR for API-I & API-II Panelav Facilities

Fermenta Receives Patent for Plant-Based Vitamin D3 Process

USFDA Concludes cGMP Audit at Cohance' API Manufacturing Plant

Bulk Drug and Intermediate Imports Grow 5% in July

Aparna Pharma Get EUGMP Certification for Pydibhimavaram Facility

Brenntag to Distribute Kerry's Pharma-Grade Acetates in EU

Finetech Launches NJP-1200 for Soft+Hard Capsule Filling

Pharma Firms Applaud Lower Drug Prices, API Tax Gap Concerns Rise

BioNxt Begins Lab-Scale ODF Development with Semaglutide API

Trump's Initiative to Strengthen US API Supply Chain Receives

CDSCO Tells SLAs to Speed Price Label Stickering Post-GST Cut

Telangana DCA Seizes Cefuroxime in Nizamabad Quack's Clinic Raid

Pharma Exporters Request Reversal of India-Only Drug Export Ban

Delhi DC Dept Targets Illegal Sale of MTP Kits Nationwide

US FTC Warns Healthcare Employers on Non-Compete Practices

US FDA Seizes $86.5M in Unauthorized E-Cigarettes

FDA Targets Drug Ads, Vows to Close Provision 'Loophole'

FDA Finds Sun Pharma's Halol Plant Non-Compliant with Rules

FDA Warns Indian Drugmaker for Quality Lapses, Enrollment Issues

CDSCO Achieves 97% Digitization for Indian Drug Regulation: DCGI

India Life Sciences Sector Moves to AI-Driven Regulatory Files

Wellness Innercell Tops Health Nutrition & Cosmetics Sector

Fangzhou Debuts 'XingShi' LLM for Chronic Disease Management